PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32920426-2	2020	In this article, a quinazolinone derivative (36b) as a NOD1/2 dual antagonist was identified that significantly sensitizes B16 tumor-bearing mice to paclitaxel treatment by inhibiting both nuclear factor kappaB (NF-kappaB) and mitogen-activated protein kinase inflammatory signaling that mediated by NOD1/2.	Quinazolinones	19-32	nucleotide-binding oligomerization domain containing 1	Mus musculus	55-61	
32920426-2	2020	In this article, a quinazolinone derivative (36b) as a NOD1/2 dual antagonist was identified that significantly sensitizes B16 tumor-bearing mice to paclitaxel treatment by inhibiting both nuclear factor kappaB (NF-kappaB) and mitogen-activated protein kinase inflammatory signaling that mediated by NOD1/2.	Quinazolinones	19-32	nucleotide-binding oligomerization domain containing 1	Mus musculus	300-306